These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 20524257)
61. Can innate immune system targets turn up the heat on 'cold' tumours? Mullard A Nat Rev Drug Discov; 2018 Dec; 17(1):3-5. PubMed ID: 29282375 [No Abstract] [Full Text] [Related]
62. [Development of anti-cancer drug: past and future]. Mano H Nihon Rinsho; 2015 Feb; 73 Suppl 2():11-5. PubMed ID: 25831717 [No Abstract] [Full Text] [Related]
63. [Perspectives of improvement of chemotherapy effectiveness in disseminated solid tumors]. Sivashinskiĭ MS Vopr Onkol; 2004; 50(2):237-42. PubMed ID: 15176230 [No Abstract] [Full Text] [Related]
64. Response and survival in clinical trials. Omura GA J Clin Oncol; 1986 Jun; 4(6):1013. PubMed ID: 3711954 [No Abstract] [Full Text] [Related]
65. Use of new cancer drugs in India. Pal SK Lancet Oncol; 2001 Dec; 2(12):716. PubMed ID: 11902509 [No Abstract] [Full Text] [Related]
74. Randomized vs. historical clinical trials. Are the benefits worth the cost? Dupont WD Am J Epidemiol; 1985 Dec; 122(6):940-6. PubMed ID: 3904415 [No Abstract] [Full Text] [Related]
75. Chemical Biology as a Driver of Innovation in Cancer Research and Drug Discovery. Kostic M; Arkin M Cell Chem Biol; 2017 Sep; 24(9):1057. PubMed ID: 28938086 [No Abstract] [Full Text] [Related]
76. Too few medicines for children with cancer. Herold R; Saint-Raymond A; Norga K JAMA Pediatr; 2014 Jun; 168(6):583. PubMed ID: 24886801 [No Abstract] [Full Text] [Related]
77. Too few medicines for children with cancer--reply. Adamson PC JAMA Pediatr; 2014 Jun; 168(6):583-4. PubMed ID: 24886802 [No Abstract] [Full Text] [Related]
78. Challenges in drug development for children. Adamson PC Clin Adv Hematol Oncol; 2017 Jan; 15(1):26-29. PubMed ID: 28212366 [No Abstract] [Full Text] [Related]
79. [The clinical trials of China innovative new anti-cancer drugs]. Shi YK; Sun Y Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):68-72. PubMed ID: 30678420 [TBL] [Abstract][Full Text] [Related]
80. Anticancer drug R&D landscape in China. Zhao S; Zhao H; Lv C; Gong J; Zhang J; Fang W; Li J; Hu X; Ba Y; Xu B; Zhang Y; Fan Y; Li K; Chen X; Yang Z; Shen L; Zhang L J Hematol Oncol; 2020 May; 13(1):51. PubMed ID: 32404176 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]